等待开盘 11-18 09:30:00 美东时间
-2.190
-1.78%
Insmed (NASDAQ:INSM) has outperformed the market over the past 5 years by 21.49% on an annualized basis producing an average annual return of 31.4%. Currently, Insmed has a market capitalization of $25.47 billion. Buying $1000 In INSM: If an investor had bought $1000 of INSM stock 5 years ago, it wo...
11-11 06:45
11月10日,Insmed(INSM)收涨1.48%,报116.1美元,成交额3.07亿美元,市值253.54亿美元。 行情数据 • 开盘价:114.83美元...
11-10 05:43
今日重点评级关注:康托·菲茨杰拉德:维持Supernus"超配"评级,目标价从67美元升至87美元;丰业银行:维持Atlas Energy Solutions"跑赢大市"评级,目标价从17美元升至18美元
11-05 14:06
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从50美元升至51美元;HC Wainwright & Co.:上调伊诺维奥制药评级至"买入",目标价5美元
11-03 18:20
11月3日,Insmed(INSM)收跌2.9%,报109.31美元,成交额4.66亿美元,市值238.71亿美元。 行情数据 • 开盘价:112.68美元 ...
11-03 05:43
Guggenheim analyst Vamil Divan maintains Insmed (NASDAQ:INSM) with a Buy and lowers the price target from $205 to $201.
11-02 22:13
ADT周升42%,获Thrive Holdings溢价逾三成收购;医药股GMAB周升30%,抗癌药临床数据表现亮眼;卡骆驰周升26%,旗下子品牌重回增长+上调全年营收指引>>
10-31 10:31
Insmed在第三季度营收达到5.244亿美元且营业亏损收窄后,上调了其2026年BRINSUPRI和ARIKAYCE营收指引的下限。
10-30 00:07
Insmed (NASDAQ:INSM) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.43) by 6.98 percent. This is a 73.71 percent increase over losses of $(1.75) per share from the same period last year. The company reported quarterly sales of $524.428 million which...
10-29 19:11
Insmed (NASDAQ:INSM) raises FY2026 sales outlook from $1.700 billion-$1.870 billion to $1.810 billion-$1.870 billion vs $1.801 billion estimate.
10-29 19:05